Vanillylmandelic Acid, 24-Hour Urine
Labcorp Test Number: 004143
Test Details: Vanillylmandelic Acid (VMA), 24-Hour Urine measures the levels of VMA in a 24-hour urine collection, aiding in the diagnosis and monitoring of neuroendocrine tumors, particularly pheochromocytoma.
Specimen Type: 24-Hour Urine
Fasting: Fasting is not applicable for this test.
Turnaround Time: Results typically accessible through the Labcorp patient portal within 1-2 weeks. Lab results will also be emailed securely via a HIPAA-compliant file-sharing service for your convenience and privacy.
Clinical Insight: VMA testing in a 24-hour urine sample is crucial for diagnosing and monitoring neuroendocrine tumors, especially pheochromocytoma.
Labcorp Test Number: 004143
Test Details: Vanillylmandelic Acid (VMA), 24-Hour Urine measures the levels of VMA in a 24-hour urine collection, aiding in the diagnosis and monitoring of neuroendocrine tumors, particularly pheochromocytoma.
Specimen Type: 24-Hour Urine
Fasting: Fasting is not applicable for this test.
Turnaround Time: Results typically accessible through the Labcorp patient portal within 1-2 weeks. Lab results will also be emailed securely via a HIPAA-compliant file-sharing service for your convenience and privacy.
Clinical Insight: VMA testing in a 24-hour urine sample is crucial for diagnosing and monitoring neuroendocrine tumors, especially pheochromocytoma.
Labcorp Test Number: 004143
Test Details: Vanillylmandelic Acid (VMA), 24-Hour Urine measures the levels of VMA in a 24-hour urine collection, aiding in the diagnosis and monitoring of neuroendocrine tumors, particularly pheochromocytoma.
Specimen Type: 24-Hour Urine
Fasting: Fasting is not applicable for this test.
Turnaround Time: Results typically accessible through the Labcorp patient portal within 1-2 weeks. Lab results will also be emailed securely via a HIPAA-compliant file-sharing service for your convenience and privacy.
Clinical Insight: VMA testing in a 24-hour urine sample is crucial for diagnosing and monitoring neuroendocrine tumors, especially pheochromocytoma.